Government Affairs
Refine Search
Biosimilars
The European Union commitment to ensuring equity of access to healthcare is challenged by the limited financial capacity of governments to cover growing demand for healthcare services. Generic and biosimilar medicines provide the greatest opportunity to improve access to safe and effective medicines through efficient medicines policies. 23 May 2017
Pharmaceutical
The policy of putting Russian drug manufacturers before foreign firms was one of many issues discussed during the Adam Smith Institute’s Russian Pharmaceutical Forum last week. 22 May 2017
Pharmaceutical
The Association of the British Pharmaceutical Industry (ABPI), the trade group representing the UK’s pharma sector, has praised parts of the manifestos proposed by Labour, the Liberal Democrats and the Conservatives. 18 May 2017
Pharmaceutical
European politicians have lent voice to calls for more funding to treat and prevent drug-resistant tuberculosis (TB), at an event organized by charities fighting the disease. 15 May 2017
Pharmaceutical
Figures from pharma are used to attempt to explain the complexities of an industry where public perception does not always reflect the reality, and such was the evident motivation in a letter written by Richard Torbett, the Association of the British Pharmaceutical Industry (ABPI) executive director, UK commercial. 10 May 2017
Pharmaceutical
The leading pharma lobby group in the USA has been working to defend drug prices at home in recent months amid President Donald Trump’s tough talk about targeting drugmakers, but with a patriotic tone that could have come from the man himself, it has now criticized other countries for not paying adequately for US innovation. 10 May 2017
Pharmaceutical
Ireland has stepped up its bid to host the European Medicines Agency (EMA) with the official announcement being delivered and reiterated by Minister of Health, Simon Harris over the past week. 9 May 2017
Generics
Doctors and public health groups in India have come up with the suggestion that the government should work for the gradual phasing out of branded drugs in a calibrated manner along with the abolition of differential pricing under different brands to give a push to generic drug prescriptions. 8 May 2017
Pharmaceutical
The Greek pharma industry, via its trade group the SfEE, has expressed its strong discontent and deep concern about the new across-the-board measures announced by the Ministry of Health (in particular the unified volume rebate, which puts an additional burden of 25% on new on-patent medicines). 8 May 2017
Pharmaceutical
The big political news last week was that US President Donald Trump finally got the House of Representatives to pass new legislation to repeal and replace The Affordable Care Act, or Obamacare. Also hitting the headlines were Lundbeck and Otsuka’s Rexulti, AstraZeneca’s Imfinzi, a Sosei acquisition, Novartis deal with Celyad, Poxel’s diabetes ambitions and Novo Nordisk results. 7 May 2017
Pharmaceutical
The new UK Health Services Medical Supplies Bill has now completed its path through Parliament and is now law. 5 May 2017
Pharmaceutical
The US House of Representatives, led by Republicans, has fulfilled its seven-year effort to undo the Affordable Care Act, commonly referred to as ‘Obamacare,’ voting to repeal and replace it by a narrow margin of 217-213 votes. 4 May 2017
Biotechnology
A trade group representing France’s biotech industry has issued a warning about the protectionist policies proposed by one of the candidates standing in Sunday’s French presidential election. 4 May 2017
Pharmaceutical
The Independent Payment Advisory Board (IPAB), a US government agency created as part of Barack Obama’s Affordable Care Act, has come under further criticism from pressure groups which are asking for it to be repealed. 2 May 2017
Pharmaceutical
The current boss of Astrazeneca in the UK has taken over the role of president at the Association of the British Pharmaceutical Industry (ABPI), the leading trade body representing pharma companies in the UK. 28 April 2017
Pharmaceutical
Few of those in attendance will disagree with the claim from the Association of the British Pharmaceutical Industry (ABPI) that this is a crucial time for the UK’s life sciences sector and National Health Service (NHS) when they gather for the trade group’s annual conference in London on Thursday. 27 April 2017
Pharmaceutical
While countries bidding to become the new home to the European Medicines Agency (EMA) are excited at the chance its likely relocation from London offers them following Brexit, a group representing the continent’s pharma associations has expressed anxiety at potential disruption the move may cause. 24 April 2017
Pharmaceutical
The Australian government is rolling out a new three-year A$5.5 million ($4.1 million) immunization awareness campaign to encourage Australian parents and carers to get their children vaccinated, the Department of Health and Ageing announced on Sunday. 24 April 2017
Pharmaceutical
While drugmakers tend to gravitate towards the mature markets, they’re also naturally keen to identify investment opportunities elsewhere. After all, sales outside of the the EU, USA and Japan account for about 20% of the global pharmaceuticals market. 24 April 2017
Pharmaceutical
A special state fund, the reserves of which will be used for the purchase of the most expensive and rare drugs, will soon be established in Russia, according to a recent initiative put forward by the members of the Russian Council of Federation, the upper house of the Russian Parliament, reports The Pharma Letter’s local correspondent. 21 April 2017
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze